Cyclacel Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Cyclacel Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $65K, a 47.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $65K -$59K -47.6% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $79K -$60K -43.2% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $93K -$49K -34.5% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $109K -$44K -28.8% Sep 30, 2023 10-Q 2023-11-29
Q2 2023 $124K -$37K -23% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $139K +$124K +827% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $142K +$112K +373% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $153K +$109K +248% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $161K +$103K +178% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $15K -$1.17M -98.7% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $30K -$1.2M -97.6% Dec 31, 2021 10-K/A 2023-11-29
Q3 2021 $44K -$1.17M -96.4% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $58K -$1.16M -95.2% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.18M +$30K +2.61% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $1.23M -$37K -2.93% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $1.22M +$2K +0.17% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $1.22M -$67K -5.21% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $1.15M -$202K -14.9% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $1.26M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $1.21M Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $1.29M Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $1.35M Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.